Search Results - "Firestone, Raymond A"

Refine Results
  1. 1
  2. 2

    The Low Energy of Concert in Many Symmetry-Allowed Cycloadditions Supports a Stepwise-Diradical Mechanism by Firestone, Raymond A.

    Published in International journal of chemical kinetics (01-07-2013)
    “…ABSTRACT The thesis of this paper is that orbital symmetry allowedness does not guarantee concert. The activation energy (Ea) for concerted Diels–Alder and…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Synthesis of an immunoconjugate of camptothecin by Walker, Michael A, Dubowchik, Gene M, Hofstead, Sandra J, Trail, Pamela A, Firestone, Raymond A

    Published in Bioorganic & medicinal chemistry letters (21-01-2002)
    “…The first immunoconjugate of camptothecin has been synthesized wherein the drug is attached to the tumor-recognizing antibody BR96 via a Cathepsin B cleavable…”
    Get full text
    Journal Article
  7. 7
  8. 8

    (6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin by Willner, David, Trail, Pamela A, Hofstead, Sandra J, King, H. Dalton, Lasch, Shirley J, Braslawsky, Gary R, Greenfield, Robert S, Kaneko, Takushi, Firestone, Raymond A

    Published in Bioconjugate chemistry (01-11-1993)
    “…The (6-maleimidocaproyl)hydrazone of doxorubicin was synthesized and conjugated to several mAbs, including chimeric BR96, via a Michael addition reaction to…”
    Get full text
    Journal Article
  9. 9

    Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study by Wang, Qun, Zhong, Yan-Jun, Yuan, Jing-Ping, Shao, Li-Hua, Zhang, Jue, Tang, Li, Liu, Shao-Ping, Hong, Ya-Ping, Firestone, Raymond A, Li, Yan

    Published in Journal of translational medicine (21-08-2013)
    “…This study was to investigate the effects and safety of cathepsin B-cleavable doxorubicin (DOX)-prodrug (PDOX) for targeting therapy of metastatic human…”
    Get full text
    Journal Article
  10. 10

    Experimental evidence of good efficacy and reduced toxicity with peptide-doxorubicin to treat gastric cancer by Zhang, Jue, Yuan, Jing-Ping, Wang, Qun, Shao, Li-Hua, Liu, Shao-Ping, Firestone, Raymond A, Hong, Ya-Ping, Li, Ji-Guo, Xin, Yan-Chao, Li, Yan

    Published in Oncotarget (05-01-2018)
    “…To compare the efficacy and toxicity of peptide-doxorubicin (PDOX) and doxorubicin (DOX) on nude mice models of human gastric cancer. Both PDOX and DOX could…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Anticancer effects of Ac-Phe-Lys-PABC-doxorubicin via mitochondria-centered apoptosis involving reactive oxidative stress and the ERK1/2 signaling pathway in MGC-803 cells by ZHONG, YAN-JUN, LIU, SHAO-PING, FIRESTONE, RAYMOND A, HONG, YA-PING, LI, YAN

    Published in Oncology reports (01-10-2013)
    “…Ac-Phe-Lys-PABC-DOX (PDOX) is a smart doxorubicin (DOX) prodrug designed to decrease toxicities while maintaining the potent anticancer effects of DOX. The…”
    Get full text
    Journal Article
  14. 14

    Synthesis, identification and in vivo studies of tumor-targeting agent peptide doxorubicin (PDOX) to treat peritoneal carcinomatosis of gastric cancer with similar efficacy but reduced toxicity by Tang, Li, Duan, Rui, Zhong, Yan-jun, Firestone, Raymond A, Hong, Ya-ping, Li, Ji-guo, Xin, Yan-chao, Wu, Han-lin, Li, Yan

    Published in Molecular cancer (03-03-2014)
    “…This work aimed to synthesize a cathepsin B (CTSB)-cleavable tumor-targeting prodrug peptide doxorubicin (PDOX) and study the in vivo efficacy and toxicities…”
    Get full text
    Journal Article
  15. 15

    Induction of cell death by the lysosomotropic detergent MSDH by Li, Wei, Yuan, XiMing, Nordgren, Gunnar, Dalen, Helge, Dubowchik, Gene M., Firestone, Raymond A., Brunk, Ulf T.

    Published in FEBS letters (17-03-2000)
    “…Controlled lysosomal rupture was initiated in lysosome-rich, macrophage-like cells by the synthetic lysosomotropic detergent, O-methyl-serine dodecylamide…”
    Get full text
    Journal Article
  16. 16

    Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Peptide Linkers:  Inhibition of Aggregation by Methoxytriethyleneglycol Chains by King, H. Dalton, Dubowchik, Gene M, Mastalerz, Harold, Willner, David, Hofstead, Sandra J, Firestone, Raymond A, Lasch, Shirley J, Trail, Pamela A

    Published in Journal of medicinal chemistry (12-09-2002)
    “…High mole ratio BR96 immunoconjugates were synthesized using branched peptide−doxorubicin linkers designed to liberate doxorubicin following antigen-specific…”
    Get full text
    Journal Article
  17. 17

    Drug giants hamstrung by timid middle management by Firestone, Raymond A

    Published in Nature (18-05-2006)
    “…A letter to the editor regarding hierarchical organizational structures in pharmaceutical companies is presented…”
    Get full text
    Journal Article
  18. 18

    Cathepsin B-sensitive dipeptide prodrugs. 1. A model study of structural requirements for efficient release of doxorubicin by Dubowchik, Gene M., Firestone, Raymond A.

    Published in Bioorganic & medicinal chemistry letters (01-12-1998)
    “…A series of lysosomal protease-sensitive peptides attached to doxorubicin (DOX) was prepared as model substrates for internalizing anticancer immunoconjugates…”
    Get full text
    Journal Article
  19. 19

    Anti-Cancer Effects of Novel Doxorubicin Prodrug PDOX in MCF-7 Breast Cancer Cells by 张珏 何良 耿霞飞 Raymond A. Firestone 洪亚平 李雁

    “…Ac-Phe-Lys-PABC-DOX(PDOX) is a smart doxorubicin(DOX) prodrug designed to decrease toxicities while maintaining the potent anticancer effects of DOX. This…”
    Get full text
    Journal Article
  20. 20